| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Baroda BNP Paribas Health and Wellness Fund IDCW |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
2.41 |
| Equity |
96.61 |
| Trep |
0.98 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
36.24% |
| Top 10 Holdings |
58.87% |
| Top 25 Holdings |
92.89% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
72.12 |
| Healthcare |
19.71 |
| Cash |
3.39 |
| Miscellaneous |
2.27 |
| Software & Services |
1.42 |
| Retail |
1.09 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
7.33 |
| PE Ratio |
47.26 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Ltd. |
8.82 |
| Torrent Pharmaceuticals Ltd. |
8.58 |
| Divis Laboratories Ltd. |
6.66 |
| Lupin Ltd |
6.46 |
| Ipca Laboratories Ltd. |
5.72 |
| Apollo Hospitals Enterprises Ltd. |
5.35 |
| Laurus Labs Limited |
5.24 |
| Fortis Healthcare Ltd |
4.55 |
| AstraZeneca Pharma India Ltd. |
4.05 |
| Glenmark Pharmaceuticals ltd |
3.44 |
| Dr. Lal Pathlabs Limited |
3.12 |
| Mankind Pharma Limited |
3.09 |
| Aurobindo Pharma Ltd. |
3.04 |
| Aster DM Healthcare Limited |
2.53 |
| Zydus Lifesciences Limited |
2.47 |
| Emcure Pharmaceuticals Limited |
2.46 |
| Net Receivables / (Payables) |
2.41 |
| Abbott India Ltd. |
2.41 |
| Max Financial Services Limited |
2.27 |
| ACUTAAS CHEMICALS LIMITED |
2.15 |
| Concord Biotech Limited |
2.05 |
| Nephrocare Health Services Limited |
1.74 |
| Metropolis Healthcare Limited |
1.46 |
| INVENTURUS KNOWLEDGE SOLUTIONS LIMITED |
1.42 |
| Ajanta Pharma Ltd. |
1.40 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|